Patients with Kallmann syndrome who experience gonadotropin-releasing hormone deficiency have been found to exhibit mutations in SEMA3A; however, regarding immune function, SEMA3A specifically has been found to act as an immune cell over-activation suppressor and is downregulated in some autoimmune diseases [22,23]. Here, SEMA3A is linked to Kallmann syndrome.